Olivier Marcq

Senior Vice President - Chemistry, Manufacturing, & Controls Tubulis

Seminars

Wednesday 10th June 2026
Reviewing the Performance of the Tubulis Tubutecan Technology From Clinic to CMC to Understand Its Advantages in Improving Stability
9:45 am
  • Exploring the superiority of the Tubutecan technology from the standpoints of quality attributes and stability
  • Sharing recent clinical data from the Tubutecan technology
  • Discussing technology development across scales toward late-stage development
Olivier Marcq - Speaker 5th World ADC South Korea Summit